CXCL1 and glioblastoma: In particular, GBM EV-treated astrocytes release great amount of growth factors (i.e. VEGF, EGF, FGF) and chemokines (i.e., CXCL1, 9,10) within the extracellular milieu, which generates a growth-stimulating medium for GBM tumor cells [38].